Subscribe
People
4 min read

Petco Adds an Outside CFO to Its Board Mid-Refinancing

Petco added Jeffrey Naylor, a former TJX chief financial officer with no ties to the private equity firms that control its board, as Audit Committee Chair effective August 1st. The appointment lands while Petco works through a $1.5 billion debt refinancing and trades near its lowest price since its 2021 IPO.

Published on
August 3, 2026
Petco Adds an Outside CFO to Its Board Mid-Refinancing

A boardroom stacked with representatives from two private equity firms just picked up its first fully independent audit chair in years.

Petco named Jeffrey Naylor, a former chief financial officer of TJX Companies, to its board of directors and Audit Committee Chair, effective August 1st. The move lands while the pet retailer works through a $1.5 billion debt refinancing and trades near its lowest share price since going public.

Petco names ex-TJX finance chief its audit chair

Petco Health and Wellness Company, the Nasdaq-listed pet retailer trading as $WOOF, appointed Naylor to its board effective August 1st and named him Audit Committee Chair immediately.

Naylor spent a decade, from 2004 to 2014, as senior executive vice president and chief financial and administrative officer at TJX Companies, the off-price retailer behind T.J. Maxx and Marshalls. He has also held chief financial officer roles at Big Lots, Dade Behring, and The Limited.

He currently chairs the board at Synchrony Financial and serves as audit committee chair at Wayfair. He was a director at Dollar Tree until recently.

CEO Joel Anderson called Naylor "a highly accomplished retail leader with a proven track record of driving profitable growth, operational discipline and financial excellence." Naylor said he sees "tremendous opportunities to build on the company's strengthening retail fundamentals."

When The Underbite checked Petco's board-of-directors page on August 3rd, it still listed ten names with no chair identified for the audit committee. That's consistent with Naylor representing an addition to an eleven-member board rather than a swap.

Why an outside financial voice matters for Petco's balance sheet

The timing says as much as the hire. Petco's board has long skewed toward the firms that took it private in 2015 and floored its 2021 IPO: Cameron Breitner and Christopher Stadler represent CVC Capital Partners, while David Lubek and Mary Sullivan represent CPP Investments. Naylor has no ties to either sponsor.

He arrives mid-refinancing. Petco launched a plan on January 12th to refinance $1.5 billion of its term loan, on top of a $50 million voluntary prepayment made in December and a $100 million board authorization for further paydowns. None of that is distressed-company behavior on its own. It is, however, active balance-sheet management at a company still carrying debt from its 2015 buyout.

The stock reflects the strain. WOOF shares trade around $2.79, per StockAnalysis.com, down roughly 85% from the $18 IPO price Petco set in January 2021, and sit near the bottom of a 52-week range that tops out at $4.19. Market cap has fallen to about $797 million.

An audit chair with no sponsor affiliation, and two other public-company board mandates including the top audit seat at Wayfair, reads less like a routine board refresh and more like a governance signal aimed at lenders and public shareholders alike. It says financial oversight no longer sits solely with the equity holders who most want the refinancing to go smoothly. Ratings agencies and term-loan lenders tend to read board-level financial credentials as a proxy for covenant discipline, especially at a company managing an active refinancing.

Public pet retailers are facing scrutiny broadly. Tractor Supply just closed roughly a third of its Petsense stores as its own pet aisle dragged on quarterly results, a reminder that balance-sheet pressure in pet retail isn't unique to Petco.

It also fits a pattern beyond Petco. Naylor is the third leadership change at a top pet company The Underbite has tracked in the past two weeks, following Mars handing its pet nutrition business to a Coca-Cola veteran and Phillips installing a new chief executive after its Central deal. Boardrooms and C-suites across the category are turning over faster than usual this summer.

What Petco's August 20th earnings call could reveal

Petco reports second-quarter results on August 20th, its first earnings call with Naylor seated as audit chair. Analysts will listen for two things beyond same-store sales: any update on the refinancing's pricing and terms, and whether management frames the board addition as part of a broader governance refresh.

A "hold" rating and a consensus price target near $3.54, roughly 27% above the current share price, suggests Wall Street already expects some improvement. The first quarter's return to positive comparable sales gives that case a foothold, though a single quarter of improvement is a thin base for a market still pricing the stock near its 52-week low.

Watch, too, for whether Petco fills additional board seats with similarly independent, sponsor-unaffiliated directors. One appointment is a data point. A second inside the next two quarters would suggest CVC and CPP are actively diluting their board footprint, not just adding a specialist for one committee.

The clearest signal will be in the numbers Naylor is now responsible for vouching for: adjusted EBITDA guidance of $395 million to $397 million for the fiscal year, a target the company reaffirmed even as it launched the refinancing.

Source: Petco via PR Newswire

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era
Funding & M&A
5 min read

GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era

GoodVets is acquiring WellHaven Pet Health's network of more than 40 hospitals, growing its footprint from 75 to 116 locations. The deal marks a shift from the de novo strategy that defined the General Atlantic-backed platform's first decade toward the acquisition-led growth every other scaled vet consolidator already runs on.

Read article
Read article
Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches
Launches
5 min read

Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches

Dechra is commercially launching Laverdia, the first FDA-approved oral treatment for canine lymphoma, developed by Anivive and licensed to Dechra in 2022. The bet isn't on winning cases from oncology referral networks, but on treating the roughly 80% of diagnosed dogs who currently get no chemotherapy at all.

Read article
Read article
PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight
People
5 min read

PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight

PetMeds named Jeff Willard as its next CEO and added two new independent directors, including a Shake Shack executive as board chair, while a $3-a-share takeover bid from SilverCape Investments remains unanswered since June. None of the three new leaders has prior ties to the company, a signal the board is building outside credibility for whatever comes next.

Read article
View all articles